Related Articles
Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway
Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors
Antitumor effects of a cyclooxygenase-2 inhibitor, meloxicam, alone and in combination with radiation and/or 5-fluorouracil in cultured tumor cells
A cyclized peptide derived from α fetoprotein inhibits the proliferation of ER-positive canine mammary cancer cells
Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells